182 related articles for article (PubMed ID: 37311723)
1. Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study.
Künzler J; Züger T; Stettler C; Laimer MW; Melmer A
Diabetes Obes Metab; 2023 Sep; 25(9):2780-2783. PubMed ID: 37311723
[No Abstract] [Full Text] [Related]
2. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
[No Abstract] [Full Text] [Related]
3. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
Müller-Korbsch M; Frühwald L; Kietaibl A
J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
[No Abstract] [Full Text] [Related]
4. Use of Advanced Hybrid Closed-Loop System in a Patient with Pancreas Cancer.
Hacisahinogullari H; Caklili OT; Saribeyliler G; Rasulova N; Selcukbiricik O; Gul N; Uzum AK; Karsidag K
Diabetes Technol Ther; 2022 Sep; 24(9):675-676. PubMed ID: 35349364
[No Abstract] [Full Text] [Related]
5. Development and Future of Automated Insulin Delivery (AID) Systems.
Garg SK; McVean JJ
Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
[No Abstract] [Full Text] [Related]
6. The Artificial Pancreas and Type 1 Diabetes.
Nwokolo M; Hovorka R
J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
[TBL] [Abstract][Full Text] [Related]
7. Human-in-the-Loop Insulin Dosing.
Bequette BW
J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
[TBL] [Abstract][Full Text] [Related]
8. Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.
Thabit H; Boughton C; Mubita W; Rubio J; Allen S; Heugh R; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Garratt C; Hovorka R; Rutter MK
Diabetes Obes Metab; 2024 Mar; 26(3):1105-1109. PubMed ID: 37984425
[No Abstract] [Full Text] [Related]
9. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.
Lemieux P; Yamamoto JM; Donovan LE
Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862
[No Abstract] [Full Text] [Related]
10. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
[TBL] [Abstract][Full Text] [Related]
11. Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings.
Henry Z; Villar Fimbel S; Bendelac N; Thivolet C
Diabetes Metab; 2022 Nov; 48(6):101396. PubMed ID: 36252880
[No Abstract] [Full Text] [Related]
12. Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery.
Thabit H; Mubita W; Rubio J; Karuppan M; Schofield J; Willinska ME; Hovorka R; Leelarathna L
Diabetes Obes Metab; 2023 Apr; 25(4):1121-1124. PubMed ID: 36514847
[No Abstract] [Full Text] [Related]
13. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
14. [What is the current state of the artificial pancreas in diabetes care?].
Dimou M; Laimer M; Stettler C; Bally L
Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
[TBL] [Abstract][Full Text] [Related]
15. Where Do We Stand with Closed-Loop Systems and Their Challenges?
Jackson M; Castle JR
Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100
[TBL] [Abstract][Full Text] [Related]
16. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
[TBL] [Abstract][Full Text] [Related]
17. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
Zhou K; Isaacs D
Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
[TBL] [Abstract][Full Text] [Related]
18. Who needs an artificial pancreas? (？).
Winikoff J; Drexler A
J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
[TBL] [Abstract][Full Text] [Related]
19. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
[TBL] [Abstract][Full Text] [Related]
20. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
Klonoff DC; Shang T; Zhang J
J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
